Antifungal Activity of 3-Hydrazinoquinoxaline-2-Thiol, a Novel Quinoxaline Derivative against Candida Species

References

• Krysan DJ. The unmet clinical need of novel antifungal drugs. Virulence. 2017;8(2):135–137. doi:10.1080/21505594.2016.1276692.
   PubMed Web of Science ®Google Scholar
• Von Lilienfeld-Toal M, Wagener J, Einsele H, et al. Invasive fungal infection: new treatments to meet new challenges. Dtsch Arztebl Int. 2019;116(16):271–278.
   PubMed Web of Science ®Google Scholar
• José P, Alvarez-Lerma F, Maseda E, et al. Invasive fungal infection in crtically ill patients: hurdles and next challenges. J Chemother. 2019;31(2):64–73. doi:10.1080/1120009X.2018.1557799.
   PubMed Web of Science ®Google Scholar
• Spencer S, Abbygail C, Brubaker KR, et al. Systemic fungal infections : a pharmacist/researcher perspective. Fungal Biol Rev. 2023;44:100293.
   Web of Science ®Google Scholar
• Mota Fernandes C, et al. The future of antifungal drug therapy: novel compounds and targets. Antimicrob Agents Chemother. 2021;65(2):1–13.
   Web of Science ®Google Scholar
• Parente-Rocha JA, Bailão AM, Amaral AC, et al. Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi. Mediators Inflamm. 2017;2017:9870679. vol doi:10.1155/2017/9870679.
   PubMed Web of Science ®Google Scholar
• Miceli MH, Kauffman CA. Isavuconazole: a new Broad-Spectrum triazole antifungal agent. Clin Infect Dis. 2015;61(10):1558–1565. doi:10.1093/cid/civ571.
   PubMed Web of Science ®Google Scholar
• Groll AH, et al. Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. Transpl Infect Dis. 2017;19(5):1–11.
   Web of Science ®Google Scholar
• Ashley ED. Antifungal drugs: special problems treating Central nervous system infections. J. Fungi. 2019;5(4):1–8.
   Web of Science ®Google Scholar
• Mayer FL, Kronstad JW. Discovery of a novel antifungal agent in the pathogen box. mSphere. 2017;2(2):e00120-17. doi:10.1128/mSphere.00120-17.
   PubMed Web of Science ®Google Scholar
• Jacobs SE, Zagaliotis P, Walsh TJ. “Novel antifungal agents in clinical trials [version 2 ; peer review : 2 approved],” 2022.
   Google Scholar
• Alfadil A, Alsamhan HA, Ali AS, et al. In vivo and in vitro antifungal activity of 2,3-Dimethylquinoxline. J Pharm Res Int. 2021;33:198–207.
   Google Scholar
• Elfadil A, Ali AS, Alrabia MW, et al. The wound healing potential of 2,3 dimethylquinoxaline hydrogel in rat excisional wound model. J Pharm Res Int. 2023;35(8):1–8. doi:10.9734/jpri/2023/v35i87339.
   Google Scholar
• Khedekar YB, Mojad AA, Malsane PN. Formulation, development, and evaluation of silymarin loaded topical gel for fungal infection. Ournal Adv Pharm. 2019;08(01):6–9.
   Google Scholar
• Cockerill FR, Wikler MA, Alder J, et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard—ninth Ed. vol. 32 (2012). Available from: https://clsi.org/media/1928/m07ed11_sample.pdf. Access, 2002.
   Google Scholar
• Tan CM, Therien AG, Lu J, et al. Restoring Methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci Transl Med. 2012;4(126):126ra35. doi:10.1126/scitranslmed.3003592.
   PubMed Web of Science ®Google Scholar
• Mikkelsen K, Sirisarn W, Alharbi O, et al. The novel membrane-associated auxiliary factors AuxA and AuxB modulate β-lactam resistance in MRSA by stabilizing lipoteichoic acids. Int J Antimicrob Agents. 2021;57(3):106283. doi:10.1016/j.ijantimicag.2021.106283.
   PubMed Web of Science ®Google Scholar
• Halawi MH, et al. Two weeks of chronic unpredictable stress are sufficient to produce oral candidiasis in balb/C mice. Asian J Microbiol Biotechnol Environ Sci. 2020;22(2):2020–2254.
   Google Scholar
• Takakura N, Sato Y, Ishibashi H, et al. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol. 2003;47(5):321–326. doi:10.1111/j.1348-0421.2003.tb03403.x.
   PubMed Web of Science ®Google Scholar
• Fathy M, Nikaido T. In vivo modulation of iNOS pathway in hepatocellular carcinoma by nigella sativa. Environ Health Prev Med. 2013;18(5):377–385.
   PubMed Web of Science ®Google Scholar
• Abdelgalil MM, Ammar YA, Elhag Ali GAM, et al. A novel of quinoxaline derivatives tagged with pyrrolidinyl scaffold as a new class of antimicrobial agents: design, synthesis, antimicrobial activity, and molecular docking simulation. J Mol Struct. 2023;1274:134443. doi:10.1016/j.molstruc.2022.134443.
   Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of america. Clin Infect Dis. 2016;62(4):e1–e50. doi:10.1093/cid/civ933.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Orsetti E, Osimani P, et al. Factors related to outcome of bloodstream infections due to Candida parapsilosis complex. BMC Infect Dis. 2016;16(1):1–7.
   PubMedGoogle Scholar
• Patil S, Rao RS, Majumdar B, et al. Clinical appearance of oral Candida infection and therapeutic strategies. Front Microbiol. 2015;6(Dec.):1391. doi:10.3389/fmicb.2015.01391.
   PubMedGoogle Scholar
• de Oliveira Santos GC, Vasconcelos CC, Lopes AJO, et al. Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents. Front Microbiol. 2018;9(Jul.):1–23. doi:10.3389/fmicb.2018.01351.
   PubMedGoogle Scholar
• Charles JI, Minakiri IS. Evaluation of the antibacterial activity of Chromolaena odorata in wistar rats and its chemical characterization. Am Sci Res J Eng Technol Sci. 2018;42(1):111–129.
   Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717. doi:10.1038/srep42717.
   PubMed Web of Science ®Google Scholar
• Cheng G, Sa W, Cao C, et al. Quinoxaline 1,4-di-N-oxides: biological activities and mechanisms of actions. Front Pharmacol. 2016;7(MAR):64. doi:10.3389/fphar.2016.00064.
   PubMedGoogle Scholar
• Chacón-Vargas KF, Andrade-Ochoa S, Nogueda-Torres B, et al. Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leishmania (Leishmania) mexicana. Parasitol Res. 2018;117(1):45–58. doi:10.1007/s00436-017-5635-3.
   PubMed Web of Science ®Google Scholar
• Gonzales PR, Pesesky MW, Bouley R, et al. Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Nat Chem Biol. vol2015;11(11):855–861. doi:10.1038/nchembio.1911.
   PubMed Web of Science ®Google Scholar
• Hutchings M, Truman A, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. 2019;51:72–80. doi:10.1016/j.mib.2019.10.008.
   PubMed Web of Science ®Google Scholar
• Ashburn TT, Thor KB. Drug repositioning : identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3(8):673–683.
   PubMed Web of Science ®Google Scholar
• Coates AR, Halls G, Hu Y. Novel classes of antibiotics or more of the same? Br J Pharmacol. 2011;163(1):184–194. doi:10.1111/j.1476-5381.2011.01250.x.
   PubMed Web of Science ®Google Scholar